A carregar...
抗病毒联合抗肝纤维化治疗慢性乙型肝炎肝纤维化降低肝细胞癌发生：144周的前瞻性队列研究
OBJECTIVE: To compare the efficacy and safety of different antiviral and antifibrotic regimens in patients with chronic hepatitis B (CHB) and hepatic fibrosis and the incidence of hepatocellular carcinoma (HCC) associated with these therapies. METHODS: A total of 840 patients with CHB and concurrent...
Na minha lista:
| Publicado no: | Nan Fang Yi Ke Da Xue Xue Bao |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
南方医科大学学报编辑部
2019
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6743913/ https://ncbi.nlm.nih.gov/pubmed/31270040 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.12122/j.issn.1673-4254.2019.06.02 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|